AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Immunocore Holdings plc American Depositary Shares
XNAS · usd
SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
FIGI BBG00YYCXG54
30.98▼ 1.14 (-3.55%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
32.12
Day's Range
30.94 – 31.80
52-Week Range
27.50 – 40.71
Volume
177.9K
Avg Volume
488.4K
Share Statistics
Shares Outstanding
Employees
524
Exchange
XNAS
Listed
2021-02-05
Share count as of July 31, 2026

Immunocore Holdings plc American Depositary Shares (IMCR) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Immunocore Holdings plc American Depositary Shares (IMCR)
What is Immunocore Holdings plc American Depositary Shares's Market Cap?
Immunocore Holdings plc American Depositary Shares's Market Cap is $1.6B, based on as-reported figures from SEC (XBRL) filings.
What is Immunocore Holdings plc American Depositary Shares's Enterprise Value?
Immunocore Holdings plc American Depositary Shares's Enterprise Value is $715.2M, based on as-reported figures from SEC (XBRL) filings.
What is Immunocore Holdings plc American Depositary Shares's Price / Sales?
Immunocore Holdings plc American Depositary Shares's Price / Sales is 3.7×, based on as-reported figures from SEC (XBRL) filings.
What is Immunocore Holdings plc American Depositary Shares's EV / Revenue?
Immunocore Holdings plc American Depositary Shares's EV / Revenue is 1.7×, based on as-reported figures from SEC (XBRL) filings.
What is Immunocore Holdings plc American Depositary Shares's EV / EBITDA?
Immunocore Holdings plc American Depositary Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Immunocore Holdings plc American Depositary Shares's Revenue (TTM)?
Immunocore Holdings plc American Depositary Shares's Revenue (TTM) is $430.8M, based on as-reported figures from SEC (XBRL) filings.
What is Immunocore Holdings plc American Depositary Shares's Net Income (TTM)?
Immunocore Holdings plc American Depositary Shares's Net Income (TTM) is -$18.1M, based on as-reported figures from SEC (XBRL) filings.
What is Immunocore Holdings plc American Depositary Shares's EBITDA?
Immunocore Holdings plc American Depositary Shares's EBITDA is -$19.5M, based on as-reported figures from SEC (XBRL) filings.
What is Immunocore Holdings plc American Depositary Shares's Diluted EPS (TTM)?
Immunocore Holdings plc American Depositary Shares's Diluted EPS (TTM) is -0.35, based on as-reported figures from SEC (XBRL) filings.
What is Immunocore Holdings plc American Depositary Shares's EBITDA Margin?
Immunocore Holdings plc American Depositary Shares's EBITDA Margin is -4.5%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · IMCRAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023
Revenue:
Total revenue
YoY growth+18.3%+13.6%+24.3%+29.2%
Cost and operating expenses:
Cost of revenue from sale of therapies
Research and development expense
Selling, general and administrative expense
Income (loss) from operations
% of revenue-2.6%6.8%-18.8%-6.9%
Other income (expense):
Interest income
Interest expense
Foreign currency gain (loss)
Other income, net
Net income (loss) before income taxes
Net income (loss)
% of revenue-0.7%12.2%-28.8%-0.2%
Basic net income (loss) per share (in USD per share)
Diluted net income (loss) per share (in USD per share)